| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.088 | 0.06 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |